Humedix Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
9,137
6,642
11,623
10,470
13,376
Depreciation, Depletion & Amortization
1,190
1,239
1,502
2,236
4,709
Other Funds
5
-
343
1
1
Funds from Operations
12,303
10,154
16,328
13,338
15,224
Changes in Working Capital
3,407
3,286
4,622
5,729
6,458
Net Operating Cash Flow
8,896
6,868
11,706
7,609
8,765
Capital Expenditures
5,022
840
10,835
22,399
19,497
Sale of Fixed Assets & Businesses
-
11
2
1
-
Purchase/Sale of Investments
1,077
8,650
6,876
3,419
5,216
Net Investing Cash Flow
3,964
9,487
17,796
20,549
20,776
Cash Dividends Paid - Total
-
-
-
2,596
4,289
Issuance/Reduction of Debt, Net
3,949
-
-
10,484
572
Net Financing Cash Flow
3,953
27,579
42,602
4,913
9,740
Net Change in Cash
978
24,960
36,513
7,954
21,736
Free Cash Flow
4,362
6,055
1,034
14,753
10,634
Net Assets from Acquisitions
-
-
-
4,582
6,237
Other Sources
-
1
31
3,360
243
Change in Capital Stock
-
27,579
42,260
2,976
4,880
Exchange Rate Effect
-
-
-
72
15
Other Uses
31
-
116
348
501

About Humedix Co.

View Profile
Address
Unit 603, Anyang Mega Valley
Anyang GY 14056
Korea, Republic Of
Employees -
Website http://www.humedix.com
Updated 09/14/2018
Humedix Co., Ltd. is a holding company, which engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. It offers dermal filler, specialty medicines, ophthalmic solvent, medicine raw materials, and cosmetics. The company was founded on February 27, 2003 and is headquartered in Anyang, South Korea.